Persistent steatosis correlates with decreased fibrosis regression during anti-HBV treatment in patients with chronic HBV infection.

导出原文传递

翻译打印收藏纠错

第一作者： Mengyang,Zhang

第一单位： Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Beijing, China.

作者： Mengyang,Zhang ^[1] ; Shuyan,Chen ^[1] ; Xiaoning,Wu ^[1] ; Jialing,Zhou ^[1] ; Tailing,Wang ^[2] ; Hui,Liu ^[3] ; Xinyan,Zhao ^[1] ; Bingqiong,Wang ^[1] ; Xinyu,Zhao ^[4] ; Yuanyuan,Kong ^[4] ; Gwyneth Shook Ting,Soon ^[5] ; Xiaojuan,Ou ^[1] ; Jidong,Jia ^[1] ; Wei,Chen ^[6] ; Yameng,Sun ^[1] ; Hong,You ^[1]

作者单位： Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Beijing, China. ^[1] Department of Pathology, China-Japan Friendship Hospital, Beijing, China. ^[2] Department of Pathology, Beijing You-an Hospital, Capital Medical University, Beijing, China. ^[3] Clinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing, China. ^[4] Department of Pathology, National University Hospital, Singapore, Singapore. ^[5] Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing, China. ^[6]

关键词 antiviral therapy fatty liver hepatic fibrosis hepatitis B lipid metabolism